NCT05604001View on ClinicalTrials.gov

In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine Fibroids

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 30, 2019

Study Completion Date

December 30, 2019

Conditions
Laser Hysteroscopic Ablation of Submucous Myoma
Interventions
DEVICE

hysteroscopic ablation of submucous uterine fibroid using diode laser

patients with symptomatic submucosal fibroids (heavy menstrual bleeding) were elected for hysteroscopy and laser ablation of the myoma

Trial Locations (4)

Unknown

Laniado University Hospital, Netanya

University of Cagliari, Cagliari

universita della campagna luigi Vanvitelli, Napoli

08003

Parc de Salut Mar, Barcelona

All Listed Sponsors
lead

Ariel University

OTHER

NCT05604001 - In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine Fibroids | Biotech Hunter | Biotech Hunter